Jacek Spławiński

893 total citations
45 papers, 718 citations indexed

About

Jacek Spławiński is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, Jacek Spławiński has authored 45 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 11 papers in Biochemistry and 10 papers in Molecular Biology. Recurrent topics in Jacek Spławiński's work include Inflammatory mediators and NSAID effects (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Jacek Spławiński is often cited by papers focused on Inflammatory mediators and NSAID effects (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Jacek Spławiński collaborates with scholars based in Poland, United States and Norway. Jacek Spławiński's co-authors include Alan S. Nies, John A. Oates, Sylwia Flis, J. Tannenbaum, Agnieszka Gnyszka, Ryszard Korbut, J A Oates, R.J. Gryglewski, Z Górka and Gryglewski Rj and has published in prestigious journals such as Circulation Research, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Jacek Spławiński

45 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacek Spławiński Poland 16 275 195 178 122 109 45 718
Jianmin Fu United States 5 604 2.2× 185 0.9× 208 1.2× 144 1.2× 68 0.6× 6 921
Shohei Higuchi Japan 16 356 1.3× 213 1.1× 103 0.6× 69 0.6× 65 0.6× 75 948
Lisa M. Antes United States 8 415 1.5× 236 1.2× 293 1.6× 46 0.4× 145 1.3× 14 841
J. R. Vane United Kingdom 9 161 0.6× 140 0.7× 92 0.5× 114 0.9× 57 0.5× 17 598
E Marcinkiewicz Poland 14 189 0.7× 177 0.9× 99 0.6× 147 1.2× 196 1.8× 31 686
A. Buntinx Belgium 14 357 1.3× 234 1.2× 81 0.5× 207 1.7× 122 1.1× 23 1.0k
Angelika Pietsch Germany 11 144 0.5× 367 1.9× 128 0.7× 157 1.3× 126 1.2× 14 1.2k
Carmine Lanni United States 15 144 0.5× 246 1.3× 47 0.3× 199 1.6× 49 0.4× 24 796
W. McKnight Canada 12 404 1.5× 108 0.6× 186 1.0× 231 1.9× 65 0.6× 14 791
Jerry Muhammad United Kingdom 4 522 1.9× 184 0.9× 153 0.9× 148 1.2× 43 0.4× 5 872

Countries citing papers authored by Jacek Spławiński

Since Specialization
Citations

This map shows the geographic impact of Jacek Spławiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Spławiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Spławiński more than expected).

Fields of papers citing papers by Jacek Spławiński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Spławiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Spławiński. The network helps show where Jacek Spławiński may publish in the future.

Co-authorship network of co-authors of Jacek Spławiński

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Spławiński. A scholar is included among the top collaborators of Jacek Spławiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Spławiński. Jacek Spławiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flis, Sylwia, Agnieszka Gnyszka, Krzysztof Flis, & Jacek Spławiński. (2009). MS275 enhances cytotoxicity induced by 5-fluorouracil in the colorectal cancer cells. European Journal of Pharmacology. 627(1-3). 26–32. 21 indexed citations
2.
Flis, Sylwia, Agnieszka Gnyszka, & Jacek Spławiński. (2009). HDAC inhibitors, MS275 and SBHA, enhances cytotoxicity induced by oxaliplatin in the colorectal cancer cell lines. Biochemical and Biophysical Research Communications. 387(2). 336–341. 33 indexed citations
3.
Flis, Sylwia, Agnieszka Gnyszka, Irena Misiewicz-Krzemińska, & Jacek Spławiński. (2009). Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205. Cancer Cell International. 9(1). 10–10. 25 indexed citations
4.
Spławiński, Jacek, et al.. (2006). Evaluation of drug toxicity in clinical trials. Science and Engineering Ethics. 12(1). 139–145. 10 indexed citations
5.
Flis, Sylwia, et al.. (2006). Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest.. PubMed. 26(4B). 3033–41. 18 indexed citations
6.
Spławiński, Jacek, et al.. (2005). Bioequivalence of two preparations of ticlopidine evaluated using a pharmacodynamic end point. International Journal of Clinical Pharmacology and Therapeutics. 43(9). 452–456. 1 indexed citations
7.
Spławiński, Jacek. (2005). Patents and ethics: Is it possible to be balanced?. Science and Engineering Ethics. 11(1). 71–74. 1 indexed citations
8.
Spławiński, Jacek, et al.. (2004). Clinical trials: active control vs placebo — What is ethical?. Science and Engineering Ethics. 10(1). 73–79. 19 indexed citations
9.
Flis, Sylwia, et al.. (2003). Anti-Angiogenic and Apoptotic Effects of Metabolites of Sulindac on Chick Embryo Chorioallantoic Membrane. PubMed. 22(1). 55–60. 11 indexed citations
10.
Spławiński, Jacek, et al.. (1989). Angiogenic activity and neovascularization in adenocarcinoma of endometrium. International Journal of Gynecology & Obstetrics. 29(4). 343–357. 9 indexed citations
11.
Szczeklik, A, et al.. (1987). Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma. Journal of Allergy and Clinical Immunology. 80(6). 839–843. 13 indexed citations
12.
Spławiński, Jacek, et al.. (1981). Bioassay of thromboxane A2 by contraction of guinea-pig lung parenchymal strip. Thrombosis Research. 21(1-2). 35–44. 2 indexed citations
13.
Rj, Gryglewski, Jacek Spławiński, & Ryszard Korbut. (1980). Endogenous mechanisms that regulate prostacyclin release.. PubMed. 7. 777–87. 17 indexed citations
14.
Spławiński, Jacek, et al.. (1979). Indomethacin increases abortifacient effect of PGE2 in man. Prostaglandins. 17(3). 451–459. 5 indexed citations
15.
Spławiński, Jacek, et al.. (1979). A New Anti‐inflammatory Derivative of Imidazole which is Less Ulcerogenic than Indomethacin in Rats. Acta Pharmacologica et Toxicologica. 45(3). 232–239. 21 indexed citations
16.
Rj, Gryglewski, Ryszard Korbut, & Jacek Spławiński. (1979). A new endocrine-like function of lungs: generation of prostacyclin.. PubMed. 10(4). 247–55. 1 indexed citations
17.
Gryglewski, R.J., Ryszard Korbut, & Jacek Spławiński. (1979). Endogenous Mechanisms which Regulate Prostacyclin Release. Pathophysiology of Haemostasis and Thrombosis. 8(3-5). 294–299. 10 indexed citations
18.
Spławiński, Jacek, et al.. (1978). Hyperthermic effects of arachidonic acid, prostaglandins E2 and F2? in rats. Pflügers Archiv - European Journal of Physiology. 374(1). 15–21. 33 indexed citations
19.
Tannenbaum, J., Jacek Spławiński, John A. Oates, & Alan S. Nies. (1975). Enhanced renal prostaglandin production in the dog. I. Effects on renal function.. Circulation Research. 36(1). 197–203. 116 indexed citations
20.
Spławiński, Jacek, Alan S. Nies, Brian J. Sweetman, & John A. Oates. (1973). THE EFFECTS OF ARACHIDONIC ACID, PROSTAGLANDIN E2 AND PROSTAGLANDIN F2α ON THE LONGITUDINAL STOMACH STRIP OF THE RAT. Journal of Pharmacology and Experimental Therapeutics. 187(3). 501–510. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianmin Fu Breakdown of academic impact, for papers by Shohei Higuchi Breakdown of academic impact, for papers by Lisa M. Antes Breakdown of academic impact, for papers by J. R. Vane Breakdown of academic impact, for papers by E Marcinkiewicz Breakdown of academic impact, for papers by A. Buntinx Breakdown of academic impact, for papers by Angelika Pietsch Breakdown of academic impact, for papers by Carmine Lanni Breakdown of academic impact, for papers by W. McKnight Breakdown of academic impact, for papers by Jerry Muhammad
Rankless by CCL
2026